• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经生理生物标志物能否区分多发性硬化症的临床亚型?

Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?

作者信息

Belvisi Daniele, Tartaglia Matteo, Borriello Giovanna, Baione Viola, Crisafulli Sebastiano Giuseppe, Zuccoli Valeria, Leodori Giorgio, Ianniello Antonio, Pasqua Gabriele, Pantano Patrizia, Berardelli Alfredo, Pozzilli Carlo, Conte Antonella

机构信息

Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy.

Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Neuromed, 86077 Pozzilli, Italy.

出版信息

Biomedicines. 2022 Jan 21;10(2):231. doi: 10.3390/biomedicines10020231.

DOI:10.3390/biomedicines10020231
PMID:35203440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8869727/
Abstract

Secondary progressive multiple sclerosis (SPMS) subtype is retrospectively diagnosed, and biomarkers of the SPMS are not available. We aimed to identify possible neurophysiological markers exploring grey matter structures that could be used in clinical practice to better identify SPMS. Fifty-five people with MS and 31 healthy controls underwent a transcranial magnetic stimulation protocol to test intracortical interneuron excitability in the primary motor cortex and somatosensory temporal discrimination threshold (STDT) to test sensory function encoded in cortical and deep grey matter nuclei. A logistic regression model was used to identify a combined neurophysiological index associated with the SP subtype. We observed that short intracortical inhibition (SICI) and STDT were the only variables that differentiated the RR from the SP subtype. The logistic regression model provided a formula to compute the probability of a subject being assigned to an SP subtype based on age and combined SICI and STDT values. While only STDT correlated with disability level at baseline evaluation, both SICI and STDT were associated with disability at follow-up. SICI and STDT abnormalities reflect age-dependent grey matter neurodegenerative processes that likely play a role in SPMS pathophysiology and may represent easily accessible neurophysiological biomarkers for the SPMS subtype.

摘要

继发进展型多发性硬化(SPMS)亚型通过回顾性诊断确定,且尚无SPMS的生物标志物。我们旨在探索灰质结构,以识别可能的神经生理学标志物,用于临床实践中更好地识别SPMS。55名多发性硬化患者和31名健康对照者接受了经颅磁刺激方案,以测试初级运动皮层内的皮质中间神经元兴奋性,并进行体感时间辨别阈值(STDT)测试,以检测皮质和深部灰质核中编码的感觉功能。使用逻辑回归模型来识别与SP亚型相关的综合神经生理学指标。我们观察到,短皮质内抑制(SICI)和STDT是区分复发缓解型(RR)与SP亚型的唯一变量。逻辑回归模型提供了一个公式,可根据年龄以及SICI和STDT的综合值计算受试者被归为SP亚型的概率。虽然在基线评估时只有STDT与残疾程度相关,但在随访时SICI和STDT均与残疾相关。SICI和STDT异常反映了年龄依赖性灰质神经退行性过程,这可能在SPMS病理生理学中起作用,并且可能代表SPMS亚型易于获取的神经生理学生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bef/8869727/5293f63b36bf/biomedicines-10-00231-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bef/8869727/14464e8a8b30/biomedicines-10-00231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bef/8869727/930ddba7e627/biomedicines-10-00231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bef/8869727/e8d2f64a5fce/biomedicines-10-00231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bef/8869727/5293f63b36bf/biomedicines-10-00231-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bef/8869727/14464e8a8b30/biomedicines-10-00231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bef/8869727/930ddba7e627/biomedicines-10-00231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bef/8869727/e8d2f64a5fce/biomedicines-10-00231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bef/8869727/5293f63b36bf/biomedicines-10-00231-g004.jpg

相似文献

1
Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?神经生理生物标志物能否区分多发性硬化症的临床亚型?
Biomedicines. 2022 Jan 21;10(2):231. doi: 10.3390/biomedicines10020231.
2
Deep grey matter involvement and altered sensory gating in multiple sclerosis.多发性硬化症中的深部灰质参与和感觉门控改变。
Mult Scler. 2020 Jun;26(7):786-794. doi: 10.1177/1352458519845287. Epub 2019 May 13.
3
The third-stimulus temporal discrimination threshold: focusing on the temporal processing of sensory input within primary somatosensory cortex.第三次刺激的时间辨别阈值:聚焦于初级体感皮层内感觉输入的时间处理
J Neurophysiol. 2017 Oct 1;118(4):2311-2317. doi: 10.1152/jn.00947.2016. Epub 2017 Jul 26.
4
Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.多发性硬化症皮质和深部灰质功能连接变化的分期。
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):205-210. doi: 10.1136/jnnp-2017-316329. Epub 2017 Oct 6.
5
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers.早期诊断继发性进展型多发性硬化症:关注体液和神经生理学标志物。
J Neurol. 2021 Oct;268(10):3626-3645. doi: 10.1007/s00415-020-09964-4. Epub 2020 Jun 5.
6
Theta-burst stimulation-induced plasticity over primary somatosensory cortex changes somatosensory temporal discrimination in healthy humans.经颅磁刺激诱导初级体感皮层的可塑性变化改变了健康人类的体感时间辨别能力。
PLoS One. 2012;7(3):e32979. doi: 10.1371/journal.pone.0032979. Epub 2012 Mar 7.
7
Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study.继发进展型多发性硬化的神经生理学和临床生物标志物:一项横断面研究。
Front Neurol. 2023 Mar 16;14:1138600. doi: 10.3389/fneur.2023.1138600. eCollection 2023.
8
Cortical dysfunction underlies disability in multiple sclerosis.皮质功能障碍是多发性硬化症致残的基础。
Mult Scler. 2012 Apr;18(4):425-32. doi: 10.1177/1352458511424308. Epub 2011 Sep 30.
9
High frequency somatosensory stimulation increases sensori-motor inhibition and leads to perceptual improvement in healthy subjects.高频体感刺激可增强感觉运动抑制,并使健康受试者的感知能力得到改善。
Clin Neurophysiol. 2017 Jun;128(6):1015-1025. doi: 10.1016/j.clinph.2017.03.046. Epub 2017 Apr 8.
10
Changes in thresholds for intracortical excitability in chronic stroke: more than just altered intracortical inhibition.慢性卒中患者皮质内兴奋性阈值的变化:不仅仅是皮质内抑制的改变。
Restor Neurol Neurosci. 2013;31(6):693-705. doi: 10.3233/RNN-120300.

引用本文的文献

1
The importance of pyramidal tract integrity for cortical plasticity and related functionality in patients with multiple sclerosis.锥体束完整性对多发性硬化症患者皮质可塑性及相关功能的重要性。
Front Neurol. 2023 Nov 24;14:1266225. doi: 10.3389/fneur.2023.1266225. eCollection 2023.
2
Multimodal diagnostics in multiple sclerosis: predicting disability and conversion from relapsing-remitting to secondary progressive disease course - protocol for systematic review and meta-analysis.多发性硬化症的多模态诊断:预测残疾和从复发缓解型向继发性进展型病程的转化-系统评价和荟萃分析方案。
BMJ Open. 2023 Jul 14;13(7):e068608. doi: 10.1136/bmjopen-2022-068608.
3

本文引用的文献

1
Altered sensorimotor integration in multiple sclerosis: A combined neurophysiological and functional MRI study.多发性硬化症中的感觉运动整合改变:一项神经生理学和功能磁共振成像的联合研究。
Clin Neurophysiol. 2021 Sep;132(9):2191-2198. doi: 10.1016/j.clinph.2021.05.028. Epub 2021 Jun 25.
2
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation.多发性硬化症患者衰弱指数的操作性定义:一项横断面研究。
Mult Scler. 2021 Oct;27(12):1939-1947. doi: 10.1177/1352458520987541. Epub 2021 Feb 10.
3
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee.
经颅磁刺激在神经障碍中的临床诊断效用。IFCN 委员会的最新报告。
Clin Neurophysiol. 2023 Jun;150:131-175. doi: 10.1016/j.clinph.2023.03.010. Epub 2023 Mar 29.
4
Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study.继发进展型多发性硬化的神经生理学和临床生物标志物:一项横断面研究。
Front Neurol. 2023 Mar 16;14:1138600. doi: 10.3389/fneur.2023.1138600. eCollection 2023.
脑灰质萎缩模式与多发性硬化临床表型和进展的相关性研究。
Neurology. 2021 Mar 16;96(11):e1561-e1573. doi: 10.1212/WNL.0000000000011494. Epub 2021 Jan 13.
4
Subtyping relapsing-remitting multiple sclerosis using structural MRI.使用结构 MRI 对复发缓解型多发性硬化进行亚型分类。
J Neurol. 2021 May;268(5):1808-1817. doi: 10.1007/s00415-020-10376-7. Epub 2021 Jan 2.
5
Is somatosensory temporal discrimination threshold a biomarker of disease progression in multiple sclerosis?体感时间辨别阈值是多发性硬化症疾病进展的生物标志物吗?
Clin Neurophysiol. 2020 Dec;131(12):2935-2936. doi: 10.1016/j.clinph.2020.09.012. Epub 2020 Oct 13.
6
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.复发缓解型多发性硬化的继发进展期转换:定义和危险因素。
Mult Scler. 2021 Mar;27(3):430-438. doi: 10.1177/1352458520974366. Epub 2020 Nov 19.
7
Identifying Progression in Multiple Sclerosis: New Perspectives.多发性硬化症的进展识别:新视角。
Ann Neurol. 2020 Sep;88(3):438-452. doi: 10.1002/ana.25808. Epub 2020 Jul 6.
8
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers.早期诊断继发性进展型多发性硬化症:关注体液和神经生理学标志物。
J Neurol. 2021 Oct;268(10):3626-3645. doi: 10.1007/s00415-020-09964-4. Epub 2020 Jun 5.
9
A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition.关注继发进展型多发性硬化症(SPMS):诊断和定义面临的挑战。
J Neurol. 2021 Apr;268(4):1210-1221. doi: 10.1007/s00415-019-09489-5. Epub 2019 Jul 30.
10
Somatosensory Temporal Discrimination Threshold in Patients with Cognitive Disorders.躯体感觉时间辨别阈值在认知障碍患者中的变化。
J Alzheimers Dis. 2019;70(2):425-432. doi: 10.3233/JAD-190385.